UK biopharmaceutical firm Apitope has developed a vaccine that could halt multiple sclerosis in its relentless march to destroy nerve cells.

The drug, called ...   more »

 Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis.

Department of Community Health Sciences,

University of Calgary,

Calgary, Alberta,

Canada...   more »

Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier.

NMR Research Unit,

Institute of Neurology,

University College London,

London, ...   more »